Abstract
The antimuscarinic potency of dibenzepin (Noveril®) was estimated by measuring (a) central in vivo effects in mice (antihypothermia and antitremor, both induced by oxotremorine), (b) peripheral in vivo activity (mydriasis caused by systemic administration of the drug), (c) the effects of dibenzepin on isolated smooth muscle from guinea pig ileum, and (d) in vitro determination of the affinity constant of dibenzepin toward the muscarinic binding sites in whole mouse-brain homogenate.
The data allowed the construction of a normalized antimuscarinic potency scale for some of the common tricyclic antidepressants. With a value of 1 for scopolamine, the following relative anticholinergic potencies were calculated: dibenzepin-1/600, nortriptyline-1/300, imipramine-1/200, and amitriptyline-1/75. These values suggest an explanation for the absence of clinically detectable anticholinergic side effects during treatment of depression with high doses of dibenzepin.
Structural and spatial interrelations among various tricyclic antidepressants and scopolamine are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armaly, M. F., Long, J. P.: Factors influencing the activity of topically applied mydriatic agents in mice. Arch. Int. Pharmacodyn. 161, 423–430 (1966)
Assael, M.: Intravenous treatment by Noveril in therapy resistant depression? Int. J. Psychopharmacol. (in press, 1977)
Biel, J. H.: Drugs affecting the central nervous system, Vol. 2, A. Burger, ed., New York: Dekker 1968
Byck, R.: The pharmacological basis of therapeutics, L. S. Goodman and A. Gilman, eds., Chap. 12. New York: MacMillan 1975
Gyermek, L.: International review of neurobiology, Vol 9, C. C. Pfeiffer and J. R. Smythies, eds. New York-London Academic Press 1966
Heflinger, F., Burckhardt, V.: Psychopharmacological agents, Vol. 1, M. Gordon, ed., Chap. 3., New York-London: Academic Press 1964
Horn, A. S., Trace, R. C. A. M.: Structure-activity relations for the inhibition of 5-hydroxytryptamine uptake by tricyclic antidepressants into synaptosomes from serotoninergic neurons in rat brain homogenates. Br. J. Pharmacol. 51, 399–403 (1974)
Kannengiesser, M. H., Hunt, P., Raynaud, J. P.: An in vitro model for the study of psychotropic drugs and as a criterion of antidepressant activity. Biochem. Pharmacol. 22, 73–84 (1973)
Kloog, Y., Sokolovsky, M.: Studies on muscarinic acetylcholine receptors from mouse brain: characterization of the interaction with antagonists. Brain Res. (in press, 1977)
Lien, E. J., Ariens, E. J., Beld A. J.: Quantitative correlations between chemical structure and affinity for acetylcholine receptors. Eur. J. Pharmacol. 35, 245–252 (1976)
Meyerhoffer, A.: The molecular structure of some anticholinergic drugs. FOA Reports 6, 1–25 (1972)
Rehavi, M., Maayani, S., Sokolovsky, M.: Tricyclic antidepressants as antimuscarinic drugs: in vivo and in vitro studies. Biochem. Pharmacol. (in press, 1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rehavi, M., Maayani, S., Goldstein, L. et al. Antimuscarinic properties of antidepressants: Dibenzepin (Noveril®). Psychopharmacology 54, 35–38 (1977). https://doi.org/10.1007/BF00426538
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00426538